Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.

Kantauskaite M, Müller L, Kolb T, Fischer S, Hillebrandt J, Ivens K, Andree M, Luedde T, Orth HM, Adams O, Schaal H, Schmidt C, Königshausen E, Rump LC, Timm J, Stegbauer J

Open source

DOI: 10.1111/ajt.16851
Published: 2022 Feb
Container: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ajt.16851,
  title = {Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.},
  author = {Kantauskaite M and Müller L and Kolb T and Fischer S and Hillebrandt J and Ivens K and Andree M and Luedde T and Orth HM and Adams O and Schaal H and Schmidt C and Königshausen E and Rump LC and Timm J and Stegbauer J},
  year = {2022},
  journal = {American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
  doi = {10.1111/ajt.16851},
  url = {https://doi.org/10.1111/ajt.16851}
}

RIS

TY  - JOUR
TI  - Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.
AU  - Kantauskaite M
AU  - Müller L
AU  - Kolb T
AU  - Fischer S
AU  - Hillebrandt J
AU  - Ivens K
AU  - Andree M
AU  - Luedde T
AU  - Orth HM
AU  - Adams O
AU  - Schaal H
AU  - Schmidt C
AU  - Königshausen E
AU  - Rump LC
AU  - Timm J
AU  - Stegbauer J
PY  - 2022
JO  - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
DO  - 10.1111/ajt.16851
UR  - https://doi.org/10.1111/ajt.16851
ER  -

APA

M, K., L, M., T, K., S, F., J, H., K, I., M, A., T, L., HM, O., O, A., H, S., C, S., E, K., LC, R., J, T., & J, S. (2022). Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. https://doi.org/10.1111/ajt.16851

Source records

pubmed · retrieved 2026-09-27T10:41:50.850Z